Jeremy Lott and Erin Wildermuth | 28 May 2007 | Baltimore Sun
AFM's Richard Tren comments on Rachel Carson's misrepresentation of facts in her 1962 book: Silent Spring.
Lorrie Goldstein | 11 May 2007 | Edmonton Sun
AFM's Richard Tren comments on how environmental groups are condemning millions to death by campaigning against the use of DDT for indoor residual spraying.
None | 11 Apr 2007 | PR.com
Immtech Pharmaceuticals, recently announced that it has initiated the second phase clinical trial for the company's oral drug candidate, pafuramidine maleate (pafuramidine), to treat patients with uncomplicated malaria caused by Plasmodium falciparum.
Michael Fumento | 02 Apr 2007 | TCS Daily
O death, where is thy sting? Far too often it comes at the end of a mosquito's proboscis. The worst mosquito-borne disease, malaria, infects about 400 million people worldwide each year (90 percent in sub-Saharan Africa) and kills about 1.3 million of them.
None | 28 Mar 2007 | News-Medical.net
People who are frequently infected with malaria parasites can develop immunity against the gametocyte, the infectious stage. This immunity inhibits the spread of the parasite.
Dennis O'Brien | 26 Mar 2007 | Baltimore Sun
Geneticall modified mosquitoes resistant to malaria have been bred at Johns Hopkins.
Staff Writers | 19 Mar 2007 | CNN
Researchers have developed a malaria-resistant mosquito, a step that might one day help block the spread of an illness that has claimed millions of lives around the world.
Will Dunham | 28 Feb 2007 | Reuters Foundation Alert Net
Scientists have achieved a greater understanding of the internal workings of the deadly malaria parasite with an eye toward developing better drugs to fight the disease, a study published on Wednesday stated.
Tove Iren S. Gerhardsen | 06 Feb 2007 | Intellectual Property Watch
A recent top-level meeting of the World Health Organization discussed member states' rights to address malaria using flexibilities in international trade and intellectual property law. But there was strong disagreement as to how far this language should go, according to sources.
Alexandra Flemming | 01 Feb 2007 | Nature
Carraz et al., reporting in PLoS Medicine, have now identified a potent lead compound that is specifically active against the obligatory primary liver stage of malaria.